Literature DB >> 4204672

Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.

G C de Gast, B Houwen, H O Nieweg.   

Abstract

The ability of purified, heat-inactivated hepatitis-B antigen (HBAg) to stimulate sensitized lymphocytes in vitro was investigated with the lymphocyte stimulation test on lymphocytes from three groups of individuals. Stimulation was minimal in the lymphocytes of two out of 15 normal controls, whereas lymphocytes from nine out of 12 patients who had recovered from hepatitis B showed stimulation, as did lymphocytes from five out of 12 laboratory technicians who had been regularly exposed to HBAg but who had no history of hepatitis or signs of it in the previous two years. No differences were observed in the responses to phytohaemagglutinin of lymphocytes from persons in the three groups. HBAg and HBAg inactivated by heat were shown in immunodiffusion to be immunologically identical. Inactivated HBAg stimulated antibody production in guinea-pigs. These findings suggest that not only humoral but also cell-mediated immunity might be induced by vaccination with purified, heat-inactivated HBAg.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4204672      PMCID: PMC1587858          DOI: 10.1136/bmj.4.5894.707

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

2.  Immunoglobulin-like surface molecules and theta antigen during the specific and non-specific stimulation of mouse spleen cells in vitro.

Authors:  T L Vischer
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

3.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

4.  Prevention of virus B hepatitis (SH hepatitis).

Authors:  J P Soulier; C Blatix; A M Courouce; D Benamon; P Amouch; J Drouet
Journal:  Am J Dis Child       Date:  1972-04

5.  Lymphocyte transformation by Australia antigen.

Authors:  A A Laiwah
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

Review 6.  The cellular basis of immunological responses. A synthesis of some current views.

Authors:  I M Roitt; M F Greaves; G Torrigiani; J Brostoff; J H Playfair
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

7.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention.

Authors:  S Krugman; J P Giles
Journal:  N Engl J Med       Date:  1973-04-12       Impact factor: 91.245

8.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

9.  Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains.

Authors:  S Krugman; J P Giles; J Hammond
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

10.  The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon.

Authors:  G Senyk; E B Williams; D E Nitecki; J W Goodman
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  13 in total

1.  Editorial: After type B hepatitis.

Authors: 
Journal:  Br Med J       Date:  1975-11-08

2.  Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

Authors:  G A Cabral; R Chairez; F Marciano-Cabral; M Suarez; G R Dreesman; J L Melnick; F B Hollinger
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

3.  Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination.

Authors:  Ru-Xiang Wang; Greet J Boland; Jan van Hattum; Gijsbert C de Gast
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

4.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

5.  Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.

Authors:  K R Beutner; M L Tiku; P L Ogra
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.

Authors:  G C De Gast; B Houwen; G K van der Hem; T H The
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

7.  Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

Authors:  H Warnatz; W Rösch; W Gerlich; W Gutmann
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

8.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Cellular immunity to the hepatitis B virion in acute hepatitis type B.

Authors:  G Fattovich; A Alberti; C Crivellaro; P Pontisso; F Noventa; G Realdi
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.

Authors:  F M Audibert; G Przewlocki; C D Leclerc; M E Jolivet; H S Gras-Masse; A L Tartar; L A Chedid
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.